Thalidomide's long and winding road.
Hanna
L
L
D000014:Abnormalities, Drug-Induced; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism*; D019247:HIV Wasting Syndrome / Q000188:drug therapy; D006297:Health Services Accessibility; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects / Q000494:pharmacology*; D007918:Leprosy / Q000188:drug therapy; D008297:Male; D008800:Mexico; D011247:Pregnancy; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration
D007917:Leprostatic Agents; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide